BGI Research is dedicated to using the world class genomics platform to contribute to the public health. Relying on innovative integration of platforms to achieve major scientific breakthroughs in the basic research area and lead technology development, BGI Research has four major areas of focus: Personal genomics, Cancer, Reproductive health, and Molecular breeding.
BGI College focus on innovative education and training for multidisciplinary talents in bioscience and bioindustry. Programs include joint education, external training (bioinformatics training, medical related training & genetic counselor training) and public education (popular science education & summer internship). More than 100 PhD students and 300 MSc students have been trained.
China National Genebank is a platform integrating a large-scale bio-repository and an omics database, operated by BGI. Genebank's mission is to collect, preserve and utilize genomics resources, and to build a network fostering global communication and collaboration on biodiversity conservation and genetic resources utilisation. We have collected over 11.3 million samples (including human, animal, plant and microbe).
GigaScience is an open-access open-data journal for the publication of all types of biological studies that use or create large-scale data sets. With the goal of revolutionizing data accessibility, dissemination, organization, and use, GigaScience has a unique format that integrates article publication with the data-hosting and cloud-computing resources. In three years GigaDB has stored over 194 datasets and 36TB data.
BGI Agriculture (BGI Agro), heardquartered in Dapeng New District, Shenzhen, is engaged in animal & plant new variety development, plantation, livestock breeding, agricultural and aquacultural farming and processing, and micro-ecological research and development with the aim to establish sustainable agricultural industry and guard national food security. BGI Agro owns world-class biological and breeding laboratories and glass greenhouses, and more than 1,600 acres of breeding and planting bases and commercial plantations.
BGI Genomics provides a wide range of commercial next generation sequencing services and a broad portfolio of genetic tests for medical institutions, research institutions and other public and private partners. BGI Genomics’ mission is to leverage its genomics expertise in order to advance life science research and to improve human health by providing high quality, affordable genomics powered health solutions for everybody.
BGI Forensics supplies accurate and affordable DNA genotyping services, and standardizes the procedures for applying relevant technologies in the fields of human DNA identification, plant and animal identification and forensics science. Based on advanced BGI sequencing platform and database, BGI Forensics provides traditional foresic services, and also focuses on the research and development of new technologies in forensic genomics, forensic pathology, and forensics. The business scope consists of DNA tests, biological reagents, instruments and ancillary products, establishing forensics industry standards, forensic science education, and forensic genomics research.
MGI, a subsidiary of BGI-the largest genomics organisation in the world, is specialised in R&D and manufacturing of proprietary instrumentation, medical devices, ancillary consumables and biological reagents e.g. genetic sequencers, mass spectrometers, medical imaging systems, and comprehensive solutions for life science research and applications. MGI owns more than 100 patents. MGI has established local technical support teams in Australia, Europe, Americas, and South-east Asia. With the vision to “enable effective and affordable healthcare solutions for all”, MGI has more than 800 employees worldwide and strives to be a leading innovator in life science technologies.